388 related articles for article (PubMed ID: 26036779)
1. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy.
Qiu L; Tang Y; Chen Y; Huang Z; Zhu Y; Zhang L; Cai L; Wan Q; Feng Y
Contrast Media Mol Imaging; 2015; 10(6):438-45. PubMed ID: 26036779
[TBL] [Abstract][Full Text] [Related]
2. Hepatic and splenic uptake on bone scintigraphy in patients with intravenous administration of 99mTc methylene diphosphonate prior to gadolinium-containing contrast.
Zhang W; Chen B; Deng H; Yang T; Ou X
Clin Nucl Med; 2013 Mar; 38(3):219-20. PubMed ID: 23412599
[TBL] [Abstract][Full Text] [Related]
3. Diffuse hepatic and splenic uptake of Tc-99m methylene diphosphonate on bone scintigraphy after intravenous administration of gadolinium-containing MRI contrast.
Shi X; Jing H; Zhuang H; Zhang Y; Jin X; Li F
Clin Nucl Med; 2011 Mar; 36(3):178-82. PubMed ID: 21285673
[TBL] [Abstract][Full Text] [Related]
4. Increased liver and spleen accumulation of Tc-99m methylene diphosphonate associated with intravenous injection of MRI contrast gadolinium-diethylenetriaminepentaacetic acid.
Zhang W; Zhang Y; Li X; Jin Z
Clin Nucl Med; 2011 Mar; 36(3):183-5. PubMed ID: 21285674
[TBL] [Abstract][Full Text] [Related]
5. (99m)Tc-interleukin-8 for imaging acute osteomyelitis.
Gratz S; Rennen HJ; Boerman OC; Oyen WJ; Burma P; Corstens FH
J Nucl Med; 2001 Aug; 42(8):1257-64. PubMed ID: 11483689
[TBL] [Abstract][Full Text] [Related]
6. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
7. Multiple extraosseous accumulation of 99mTc-MDP in acute lymphocytic leukemia and reference to literature.
Xu YH; Song HJ; Qiu ZL; Luo QY
Hell J Nucl Med; 2010; 13(3):273-6. PubMed ID: 21193884
[TBL] [Abstract][Full Text] [Related]
8. Hepatic uptake of Tc-99m DPD on bone scintigraphy: the influence of the interval with gadolinium-containing contrast of MRI.
Pak K; Kim SJ; Kim IJ; Suh KT
Clin Nucl Med; 2012 Feb; 37(2):134-6. PubMed ID: 22228334
[TBL] [Abstract][Full Text] [Related]
9. Different findings in Tc-99m MDP bone scintigraphy of patients with sickle cell disease: report of three cases.
Cerci SS; Suslu H; Cerci C; Yildiz M; Ozbek FM; Balci TA; Yesildag A; Canatan D
Ann Nucl Med; 2007 Jul; 21(5):311-4. PubMed ID: 17634851
[TBL] [Abstract][Full Text] [Related]
10. Intense splenic 99mTc-MDP uptake in a patient with myelofibrosis.
Chen M; Liu C; Yang J
Clin Nucl Med; 2013 Dec; 38(12):1022-4. PubMed ID: 24152662
[TBL] [Abstract][Full Text] [Related]
11. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
12. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
13. Does cisplatin chemotherapy decrease the MDP uptake of normal bone? An experimental study.
Ozdogan O; Ertay T; Arslan G; Sisman AR; Capa Kaya G; Yilmaz O; Coker C; Gure A; Durak H
Ann Nucl Med; 2008 Jun; 22(5):357-62. PubMed ID: 18600412
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric considerations of
Brown JL; Sexton-Stallone B; Li Y; Frey EC; Treves ST; Fahey FH; Plyku D; Cao X; Choi C; Kim CH; Sgouros G; Aris JP; Bolch WE
Phys Med Biol; 2020 Dec; 65(23):235025. PubMed ID: 33263312
[TBL] [Abstract][Full Text] [Related]
15. Bilateral lung 99mTc-MDP uptake on the bone scintigraphy in the myelodysplastic syndromes (MDS).
Mogharrabi M; Javadi H; Assadi M
Clin Nucl Med; 2013 May; 38(5):372-4. PubMed ID: 23531771
[TBL] [Abstract][Full Text] [Related]
16. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
17. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of vascularized bone: quantitative analysis of bone scintigraphy and histology.
Takato T; Harii K; Nakatsuka T; Ohtake T
J Reconstr Microsurg; 1988 Oct; 4(5):391-7. PubMed ID: 3058962
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
[TBL] [Abstract][Full Text] [Related]
20. Pathologic hepatic Tc-99m-MDP uptake in polyostotic fibrous dysplasia.
Kekilli E; Yagmur C; Kuzucu A; Soysal O; Cikim AS; Ertem K
Ann Nucl Med; 2004 Oct; 18(7):627-30. PubMed ID: 15586638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
